STEVEN LAPLANTE: Open Payments
NPI 1336318013 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 91 payments from 24 companies in 2025. Trend: 2023 $2,010 · 2024 $1,825 · 2025 $1,754
Food & beverage: $1,754
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $309 |
| ABBVIE INC. | 17 | $247 |
| Lundbeck LLC | 19 | $201 |
| Nalu Medical, Inc. | 1 | $184 |
| SI-BONE, INC. | 2 | $99 |
| UCB, Inc. | 3 | $97 |
| Neurocrine BioSciences, Inc. | 4 | $79 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $76 |
| Noctrix Health, Inc. | 1 | $54 |
| SK Life Science, Inc. | 3 | $53 |
Products named: NURTEC ODT, Nalu Neurostimulation System, QULIPTA, VYEPTI, INGREZZA, JOURNAVX, UBRELVY, REXULTI.
Industry payments across NY — which companies pay providers there.
